SCHEMBL17666366

SCHEMBL17666366

c1ccc(Nc2ccc(-c3ccc(Nc4ccc(C5(c6ccc(Nc7ccc(-c8ccc(Nc9ccccc9)cc8)cc7)cc6)CCCCC5)cc4)cc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
SLC6A2 P23975 4/20 0.46
HSD17B10 Q99714 4/20 0.46
ALOX12 P18054 4/20 0.46
TDP1 Q9NUW8 4/20 0.46
ALOX15 P16050 3/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 3/20 0.46
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
HTR2B P41595 1/20 0.46
ESR1 P03372 2/20 0.46
ESR2 Q92731 2/20 0.46
LMNA P02545 4/20 0.45
MAPT P10636 4/20 0.45
SLC6A4 P31645 3/20 0.45
SLC6A3 Q01959 3/20 0.45
HTT P42858 3/20 0.45
THRB P10828 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8620004 0.94 ALDH1A1 (0.52) ALDH1A1L3MBTL1SLC6A2HSD17B10ALOX12
SCHEMBL8647058 0.89 ALDH1A1 (0.39) ALDH1A1L3MBTL1SLC6A2HSD17B10ALOX12
SCHEMBL1021921 0.81 HPGD (0.57) ALDH1A1ALOX12HTR2BLMNAMAPT
SCHEMBL11152421 0.80 ESR1 (0.65) ALDH1A1L3MBTL1SLC6A2ALOX12ESR1
SCHEMBL2046010 0.78 MAPT (0.51) ALDH1A1L3MBTL1ALOX12HTR2BESR1
SCHEMBL24157288 0.76 ESR1 (0.58) ALDH1A1L3MBTL1SLC6A2ESR1ESR2
SCHEMBL30877914 0.76 ESR1 (0.58) ALDH1A1L3MBTL1SLC6A2ESR1ESR2
SCHEMBL30877902 0.76 ESR1 (0.58) ALDH1A1L3MBTL1SLC6A2ESR1ESR2
SCHEMBL30078304 0.76 ESR1 (0.58) ALDH1A1L3MBTL1SLC6A2ESR1ESR2
SCHEMBL28378542 0.76 ESR1 (0.58) ALDH1A1L3MBTL1SLC6A2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244882-A1 DISPLAY DEVICE AND MANUFACTURING METHOD OF DISPLAY DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-07-18 US disclosed
US-20230403920-A1 METHOD OF MANUFACTURING DISPLAY PANEL AND THE DISPLAY PANEL SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-12-14 US disclosed
US-20230292544-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-14 US disclosed
US-20230276700-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-08-31 US disclosed
WO-2016052252-A1 CHARGE-TRANSPORTING VARNISH 日産化学工業株式会社 2016-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276700-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SLC43A1, SLC7A5, SLCO4C1 ALDH1A1 642/4885L3MBTL1 2143/4885SLC6A2 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.